Smart Money · Holder IQ
78 / 100
Above median holder quality (percentile 96.6 this quarter). Tracked high-scoring holders are adding shares.
ACRV
Acrivon Therapeutics, Inc. Common StockNASDAQ
$1.46-7.01%
Close Nov 12, 2026
Reading stored signals…
Healthcare • Biotechnology
Factor tilt: Micro-Cap Value
People-network credibilityUncalibrated
No reporting owner has a RED or GREEN connection distinguishable from zero in this publication.
Show all 20 reporting owners
- Charles M. BaumDirector — as filedRED 0.000001 · GREEN 0 · Net -0.000001
- Peter Blume-JensenPresident and CEO · Director — as filedRED 0 · GREEN 0 · Net 0
- Eric DevroeChief Operating Officer — as filedRED 0 · GREEN 0 · Net 0
- Derek DiRoccoDirector — as filedRED 0 · GREEN 0 · Net 0
- Erick GamelinChief Development Officer — as filedRED 0 · GREEN 0 · Net 0
- Peter KolchinskyDirector · 10% reporting owner — as filedRED 0.000001 · GREEN 0 · Net -0.000001
- Michaela LevinChief Business Officer — as filedRED 0 · GREEN 0 · Net 0
- Adam D. LevyChief Financial Officer — as filedRED 0 · GREEN 0 · Net 0
- Ivana Magovcevic-LiebischDirector — as filedRED 0.000001 · GREEN 0 · Net -0.000001
- Kristina MassonEVP - Business Operations · Director — as filedRED 0 · GREEN 0 · Net 0
- Mary MillerChief Legal Officer — as filedRED 0 · GREEN 0 · Net 0
- Mansoor Raza MirzaChief Medical Officer — as filedRED 0 · GREEN 0 · Net 0
- Santhosh PalaniDirector — as filedRED 0 · GREEN 0 · Net 0
- Katharine PetersonChief Accounting Officer — as filedRED 0 · GREEN 0 · Net 0
- RA Capital Healthcare Fund LPDirector · 10% reporting owner — as filedRED 0 · GREEN 0 · Net 0
- RA CAPITAL MANAGEMENT, L.P.Director · 10% reporting owner — as filedRED 0 · GREEN 0 · Net 0
- RA Capital Nexus Fund II, L.P.Director — as filedRED 0 · GREEN 0 · Net 0
- Sharon ShachamDirector — as filedRED 0 · GREEN 0 · Net 0
- Rajeev M. ShahDirector · 10% reporting owner — as filedRED 0.000001 · GREEN 0 · Net -0.000001
- Michael John TomsicekDirector — as filedRED 0 · GREEN 0 · Net 0
How this is measured
A connection is distinguishable from zero here only when its RED or GREEN published interval has a lower bound above zero. A person with an admitted finding is always listed first, even with a zero score. Connections are then ordered by the larger of RED and GREEN. A zero tied with other owners is not given a percentile.
RED measures graph connections to people with admitted adjudications; GREEN measures connections to repeat value creators and stewards of qualifying compounders and long-term shareholder-return leaders. Net is GREEN minus RED on a −1 to 1 scale, not a probability or expected return. Connections alone do not establish conduct. These measures are separate from insider trading performance and Company Quality Grade.
The publication is uncalibrated. Its intervals are published bands, not a claim of calibrated confidence or a tested forecast.
Admitted findings are published guilty pleas, convictions and litigated SEC judgments or orders. Settlements and open cases are not findings. A positive net does not erase an admitted finding. Absence of a finding is not a clearance or a complete regulatory-history search.
Reporting owners who filed from after Oct 9, 2025 through Oct 9, 2026: a 12-month window ending at the publication date. This can include former officers and directors; it is not a verified roster of today's employees.
Link an account to see your stake, watchlist and past holdings. use the cited filings to check the reported role and evidence alongside your investment thesis. A connection alone does not tell you to increase or reduce a holding.
Medians across all 20 scored reporting owners at this company as of Oct 9, 2026: RED 0, GREEN 0, net 0. Highest RED: 0.000001; highest GREEN: 0.
- Issuer CIK
- 0001781174
- Publication as of
- Oct 9, 2026; known by Oct 9, 2026
- Retrieved
- Nov 13, 2026; a new publication can take up to six hours to appear here
- RED source refresh state
- fresh within 8d
- Method
- epg.signed_credibility.raw-uncalibrated.v1
- Population identity
- sha256:733e7e30f755f296f1d478ccb2c8674cb0adf04ebbe89319e08bc8255dddb9c5
- Graph identity
- c6521b138848011b775d9a6dfb7ac59989b2082fdc729ef4f41456a4e2037f60
- Source
- SEC Forms 3, 4 and 5 for roles; the Midas Edge API's active immutable people-network publication for credibility and admitted findings. GREEN seed evidence can include vendor price histories. No portfolio or account data is sent to this product.
Charles M. Baum · SEC CIK 0001579824
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.020001; GREEN 0 to 0.02; net -0.040001 to 0.039999.
Score identity: f9deac4791edbf8eea8346f6783fba7153290ee923ec6dcad9cbf289596c1fab
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Peter Blume-Jensen · SEC CIK 0001950499
Read the Form 4 filed Aug 27, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: a7e942aa8d30cb2ca924795564e906be3e0d0d94249c77287eeb74edbf5018e5
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Eric Devroe · SEC CIK 0001950573
Read the Form 4 filed Aug 20, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: ff9384e1ac433e1307d003266b1967951892af4b2b91b7f32d3ff9e81accbd54
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Derek DiRocco · SEC CIK 0001792061
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: d968009e95e819cc2a6bad300d2d62dd6ae7292ce4d32b5fa65079dd27f6ede7
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Erick Gamelin · SEC CIK 0001950551
Read the Form 4 filed Aug 20, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: f72f73855255b4526b7c7a5610a917b085d88fb33a3e29e4a47887c03354e245
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Peter Kolchinsky · SEC CIK 0001384859
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.020001; GREEN 0 to 0.02; net -0.040001 to 0.039999.
Score identity: a063ed2b9f00b406e7cd9700de8e423bf6ccd0ecf461a2803034b3db09e4cdbf
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Michaela Levin · SEC CIK 0002151012
Read the Form 4 filed Sep 2, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 34e44e66ef32ba1f967ca742b4526e0238d869f564fc0d14395246fb670c5685
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Adam D. Levy · SEC CIK 0002061876
Read the Form 4 filed Aug 6, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 8154da61633fd55aa543783d2f81650ba948fd2b67033cd58a09ca252baf9f0d
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Ivana Magovcevic-Liebisch · SEC CIK 0001279281
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.020001; GREEN 0 to 0.02; net -0.040001 to 0.039999.
Score identity: ec9f9a79ccfe0d3b4cedfdd8819872f81c78d9ad577fb8afae57bb4413a6e8e6
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Kristina Masson · SEC CIK 0001950501
Read the Form 4 filed Aug 27, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 3c04f0d971b6cc54f6d151f4c9675dc55a7c650d9aeb9b3eca0797b05dfc3d5e
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Mary Miller · SEC CIK 0001841088
Read the Form 4 filed Oct 7, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 4ae8e242be76b4dcdbd1a0b6de12c701a81a5bfa8c4cec0eb557ef0c1b8754ed
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Mansoor Raza Mirza · SEC CIK 0001588389
Read the Form 4 filed May 20, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: f06953f3c8871a433b1af9817feb159eedcd53299446396b70c27db2e2982d05
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Santhosh Palani · SEC CIK 0002013475
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 4fc091874067528299d5fcaeaa7946dd5af52364ee4ae8d96f7167d1a319e904
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Katharine Peterson · SEC CIK 0002022214
Read the Form 4 filed Aug 20, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 6967c0b252b09adbb0cf943d8b356011e9cf7474b34aee5c28d1e5162f59a7fa
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
RA Capital Healthcare Fund LP · SEC CIK 0001315082
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: a9956a76ee6a0b2dbbc410618ff693954338ee11e60e4501bc2b50f961e516c1
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
RA CAPITAL MANAGEMENT, L.P. · SEC CIK 0001346824
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 130b483153b58b0b1054c5c826b4340816ea233ef4e6e588dbb987ede1d926b0
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
RA Capital Nexus Fund II, L.P. · SEC CIK 0001825376
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 69a4a2f00e8134ac2c15033f1b2db103afce6b76a8bf9f593ccd210aba8d7740
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Sharon Shacham · SEC CIK 0001588438
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 8860411b52bffdbfcc3f06217bc1ce159903a06013846514bdbf06bafe549ecb
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Rajeev M. Shah · SEC CIK 0001619841
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.020001; GREEN 0 to 0.02; net -0.040001 to 0.039999.
Score identity: 24f11d8ec7b2efab153347d84d1446c1f623080c2f5b80de66a79f9921034069
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Michael John Tomsicek · SEC CIK 0001570392
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: d72e6dd1a8103c83b9a08f41e242df839b218fce23df1d3f33b0c5b331bf0074
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
- Market cap
- $61.09M
- 1 month
- -15.1%
- 3 months
- -25.1%
- 1 year
- -29.5%
- 52-week range
- $1.29$3.01
More market facts
- Dividend
- No dividends on record
- Latest-quarter EPS estimate
- -$0.44Quarter ended Sep 30, 2026 · 5 analysts · 0.0% in 30d
- Short interest
- 7.0% of float1.8M shares · settled Oct 30, 2026 · +3.9% since Oct 15, 2026 · FINRA
Estimate history · same fiscal quarter
Quarter ended Sep 30, 2026. Source: Stored analyst estimates.
| Observed / analysts | EPS | Revenue |
|---|---|---|
| 5 analysts | -0.438 | — |
| 5 analysts | -0.438 | — |
| 5 analysts | -0.438 | — |
| 5 analysts | -0.438 | — |
| 5 analysts | -0.438 | — |
Dates identify stored observations, not earnings announcements. Gaps do not mean estimates were unchanged. The analyst group and vendor earnings basis may change.
Link an account to see your stake, watchlist and past holdings. Compare changes in earnings expectations with your investment case. These are analyst estimates, not reported results or a prediction of your return.
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- —
- Net income
- -$74.23M
- Free cash flow
- -$64.14M
- Book value
- $86.67M
- Total debt
- $2.12M
- P/E
- —
- Price / sales
- —
- Price / book
- 0.7×
- FCF yield
- -105.0%
- Net margin
- —
Trailing twelve-month statements · as of Nov 12, 2026
End-of-day close from stored market data, not a live quote.
About Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.
Read more
The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 for the treatment of patients with endometrial and platinum-resistant ovarian cancer, and SCCs, such as SCCHN and anal cancer. The company is also developing ACR-2316, a dual WEE1 and PKMYT1 inhibitor small molecule candidate; and a preclinical stage AP3-and co-crystallography-based preclinical cell cycle program. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
- Website
- acrivon.com
- Headquarters
- Watertown, MA, United States
- Employees
- 74
- Listed
- Nov 15, 2022
- Fiscal year ends
- December
Company profile stored Oct 27, 2026.
Quarterly results
The last 8 fiscal quarters from the latest stored normalized financial statements. These may include restatements. Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 12, 2026 | — | — | — | -$18.7M | -$18.0M |
| Mar 2026filed May 13, 2026 | — | — | — | -$19.9M | -$19.0M |
| Dec 2025filed Mar 19, 2026 | — | — | — | -$20.1M | -$19.0M |
| Sep 2025filed Nov 13, 2025 | — | — | — | -$19.7M | -$18.2M |
| Jun 2025filed Aug 13, 2025 | — | — | — | -$22.6M | -$21.0M |
| Mar 2025filed May 14, 2025 | — | — | — | -$21.7M | -$19.7M |
| Dec 2024filed Mar 27, 2025 | $848.0K | -55.0% | — | -$25.0M | -$22.8M |
| Sep 2024filed Nov 13, 2024 | — | — | — | -$25.1M | -$22.4M |
Balance sheet · cash, debt and near-term obligations
What resources sit beside the obligations? These are balances at each fiscal quarter end, not cash earned during the quarter. Amounts are in USD, the reporting currency.
As of
- Reported cash
- $41.4M
- Reported total debt
- $2.1M
- Current assets
- $91.5M
- Current liabilities
- $11.4M
Vendor filing date:
As of
- Reported cash
- $34.1M
- Reported total debt
- $2.4M
- Current assets
- $99.2M
- Current liabilities
- $11.1M
Vendor filing date:
As of
- Reported cash
- $41.5M
- Reported total debt
- $2.7M
- Current assets
- $120.4M
- Current liabilities
- $15.7M
Vendor filing date:
As of
- Reported cash
- $35.4M
- Reported total debt
- $3.0M
- Current assets
- $130.4M
- Current liabilities
- $14.9M
Vendor filing date:
Link an account to see your stake, watchlist and past holdings. Compare cash and debt across dates when reviewing its reliance on financing. Current assets can include receivables and inventory; current liabilities include bills as well as borrowings. They are not all spendable cash or all debt. These figures alone do not establish the ability to repay.
Source: the latest stored normalized balance sheets, matched to the same security and fiscal end as these income periods. They may include restatements and are not an originally-filed or knowledge-time history. No net debt, coverage ratio or replacement balance is calculated. Read the SEC guide to financial statements for the distinction between balances and cash flows.
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 19, 2026 | — | — | — | -$84.1M | -$77.9M |
| Dec 2024filed Mar 27, 2025 | — | — | — | -$89.2M | -$80.6M |
| Dec 2023filed Mar 28, 2024 | — | — | — | -$67.2M | -$60.4M |
| Dec 2022filed Mar 28, 2023 | — | — | — | -$32.7M | -$29.7M |
| Dec 2021filed Dec 31, 2021 | — | — | — | -$16.2M | -$16.2M |
| Dec 2020filed Dec 31, 2020 | — | — | — | -$3.2M | -$5.3M |
Annual cash generation
Does profit turn into cash? Compare ACRV’s accounting profit with operating cash flow and capital spending. Amounts are in USD.
Fiscal year ending
- Net income
- -$77.9M
- Operating cash flow
- -$63.7M
- Capital spending
- $1.7M
- Free cash flow
- -$65.3M
Fiscal year ending
- Net income
- -$80.6M
- Operating cash flow
- -$65.7M
- Capital spending
- $2.8M
- Free cash flow
- -$68.4M
Fiscal year ending
- Net income
- -$60.4M
- Operating cash flow
- -$42.6M
- Capital spending
- $1.3M
- Free cash flow
- -$43.9M
Earlier cash-flow years
Fiscal year ending
- Net income
- -$29.7M
- Operating cash flow
- -$30.1M
- Capital spending
- $2.2M
- Free cash flow
- -$32.3M
Fiscal year ending
- Net income
- -$16.2M
- Operating cash flow
- -$14.0M
- Capital spending
- $238.0K
- Free cash flow
- -$14.2M
Fiscal year ending
- Net income
- -$5.3M
- Operating cash flow
- -$2.8M
- Capital spending
- $15.0K
- Free cash flow
- -$2.8M
Link an account to see your stake, watchlist and past holdings. Compare cash generation and investment needs with your thesis. Working capital and non-cash charges can separate profit from cash. Capital spending can reduce free cash flow while earnings rise. For a long or short position, that gap alone does not predict a price move.
Cash-flow source and meaning
Source: Annual financial statements, latest stored vendor-normalized figures. These may include restatements and may differ from the filer’s own XBRL. A filing date is not the knowledge date of this version of the values.
Free cash flow is the vendor’s reported figure, shown only when it agrees with operating cash flow less capital spending recorded as a positive outflow. It is not cash guaranteed for dividends or buybacks, and it does not subtract every financing obligation. Missing or sign-incompatible inputs are not filled in. An unlabelled currency is used only for a confirmed domestic USD filer. These are annual statements, not forecasts or an originally-filed history.
Cash allocation: dividends, shares and debt
Where did ACRV’s financing cash go? Compare cash paid as dividends with net share and debt transactions across fiscal years. Amounts are in USD, the reporting currency. These are company-wide totals, not per-share payouts.
Fiscal year ended
Vendor filing date:
- Total financing cash flow
- -$749.0K
Fiscal year ended
Vendor filing date:
- Total financing cash flow
- $121.0M
Fiscal year ended
Vendor filing date:
- Total financing cash flow
- -$1.6M
Fiscal year ended
Vendor filing date:
- Net share issuance / purchases
- $101.7M
- Total financing cash flow
- $101.7M
Fiscal year ended
Vendor filing date:
- Net borrowing / repayment
- $0.0
- Total financing cash flow
- $112.2M
Fiscal year ended
Vendor filing date:
- Net borrowing / repayment
- $58.0K
- Total financing cash flow
- $2.9M
Link an account to see your stake, watchlist and past holdings. Compare these uses of cash with operating cash generation and the debt on the balance sheet. A negative net share movement means purchases exceeded issuance; it does not give gross buybacks. A dividend or share purchase can be financed with borrowing, and none of these flows guarantees a future payment or price return.
Allocation source and sign conventions
Source: Annual cash-flow statements, latest stored vendor-normalized values for the same security and fiscal year. These can include restatements; a filing date is not the knowledge date of this version.
Dividends are positive cash paid out. For net share transactions, net borrowing and total financing, positive means cash in and negative means cash out. Net share transactions combine issuance and purchases; they are not gross repurchases, a change in shares outstanding, or stock compensation. Total financing includes other flows and is not the sum of just these three lines. Zero means a reported zero. No FX conversion, shareholder-return total or forecast is inferred.
Short-interest history
Reported short positions, stored float percentages and adjusted prices over the same period.
Shares short
Share of float
Adjusted close · USD
Settlement records · 95 observations
Settlement Oct 30, 2026
1,804,674 shares short
+66,985 shares (+3.9%) vs Oct 15, 2026
7% of the stored float. Published Nov 10, 2026.
Settlement Oct 15, 2026
1,737,689 shares short
+120,962 shares (+7.5%) vs Sep 30, 2026
6.7% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
1,616,727 shares short
+414,108 shares (+34.4%) vs Sep 15, 2026
6.3% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
1,202,619 shares short
+63,382 shares (+5.6%) vs Aug 31, 2026
4.3% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
1,139,237 shares short
-96,656 shares (-7.8%) vs Aug 14, 2026
4.1% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
1,235,893 shares short
-119,122 shares (-8.8%) vs Jul 31, 2026
Published Aug 25, 2026.
Settlement Jul 31, 2026
1,355,015 shares short
-132,430 shares (-8.9%) vs Jul 15, 2026
Published Aug 11, 2026.
Settlement Jul 15, 2026
1,487,445 shares short
-1,352,903 shares (-47.6%) vs Jun 30, 2026
Published Jul 24, 2026.
Settlement Jun 30, 2026
2,840,348 shares short
+13,014 shares (+0.5%) vs Jun 15, 2026
Published Jul 10, 2026.
Settlement Jun 15, 2026
2,827,334 shares short
+25,342 shares (+0.9%) vs May 29, 2026
Published Jun 25, 2026.
Settlement May 29, 2026
2,801,992 shares short
+305,824 shares (+12.3%) vs May 15, 2026
Published Jun 9, 2026.
Settlement May 15, 2026
2,496,168 shares short
+32,433 shares (+1.3%) vs Apr 30, 2026
Published May 27, 2026.
Settlement Apr 30, 2026
2,463,735 shares short
+75,578 shares (+3.2%) vs Apr 15, 2026
Published May 11, 2026.
Settlement Apr 15, 2026
2,388,157 shares short
+202,297 shares (+9.3%) vs Mar 31, 2026
Published Apr 24, 2026.
Settlement Mar 31, 2026
2,185,860 shares short
-222,054 shares (-9.2%) vs Mar 13, 2026
Published Apr 10, 2026.
Settlement Mar 13, 2026
2,407,914 shares short
+272,471 shares (+12.8%) vs Feb 27, 2026
Published Mar 24, 2026.
Settlement Feb 27, 2026
2,135,443 shares short
-192,444 shares (-8.3%) vs Feb 13, 2026
Published Mar 10, 2026.
Settlement Feb 13, 2026
2,327,887 shares short
+303,260 shares (+15%) vs Jan 30, 2026
Published Feb 25, 2026.
Settlement Jan 30, 2026
2,024,627 shares short
-5,496,517 shares (-73.1%) vs Jan 15, 2026
Published Feb 10, 2026.
Settlement Jan 15, 2026
7,521,144 shares short
+2,195,820 shares (+41.2%) vs Dec 31, 2025
Published Jan 27, 2026.
Settlement Dec 31, 2025
5,325,324 shares short
+203,615 shares (+4%) vs Dec 15, 2025
Published Jan 12, 2026.
Settlement Dec 15, 2025
5,121,709 shares short
+765,656 shares (+17.6%) vs Nov 28, 2025
Published Dec 24, 2025.
Settlement Nov 28, 2025
4,356,053 shares short
+653,121 shares (+17.6%) vs Nov 14, 2025
Published Dec 9, 2025.
Settlement Nov 14, 2025
3,702,932 shares short
+1,978,413 shares (+114.7%) vs Oct 31, 2025
Published Nov 25, 2025.
Settlement Oct 31, 2025
1,724,519 shares short
+89,238 shares (+5.5%) vs Oct 15, 2025
Published Nov 11, 2025.
Settlement Oct 15, 2025
1,635,281 shares short
+483,916 shares (+42%) vs Sep 30, 2025
Published Oct 24, 2025.
Settlement Sep 30, 2025
1,151,365 shares short
-126,497 shares (-9.9%) vs Sep 15, 2025
Published Oct 9, 2025.
Settlement Sep 15, 2025
1,277,862 shares short
+716,045 shares (+127.5%) vs Aug 29, 2025
Published Sep 24, 2025.
Settlement Aug 29, 2025
561,817 shares short
-146,603 shares (-20.7%) vs Aug 15, 2025
Published Sep 10, 2025.
Settlement Aug 15, 2025
708,420 shares short
+12,052 shares (+1.7%) vs Jul 31, 2025
Published Aug 26, 2025.
Settlement Jul 31, 2025
696,368 shares short
+97,764 shares (+16.3%) vs Jul 15, 2025
Published Aug 11, 2025.
Settlement Jul 15, 2025
598,604 shares short
-165,101 shares (-21.6%) vs Jun 30, 2025
Published Jul 24, 2025.
Settlement Jun 30, 2025
763,705 shares short
-361,080 shares (-32.1%) vs Jun 13, 2025
Published Jul 10, 2025.
Settlement Jun 13, 2025
1,124,785 shares short
+78,589 shares (+7.5%) vs May 30, 2025
Published Jun 25, 2025.
Settlement May 30, 2025
1,046,196 shares short
-292,715 shares (-21.9%) vs May 15, 2025
Published Jun 10, 2025.
Settlement May 15, 2025
1,338,911 shares short
-54,809 shares (-3.9%) vs Apr 30, 2025
Published May 27, 2025.
Settlement Apr 30, 2025
1,393,720 shares short
+683,215 shares (+96.2%) vs Apr 15, 2025
Published May 9, 2025.
Settlement Apr 15, 2025
710,505 shares short
-176,608 shares (-19.9%) vs Mar 31, 2025
Published Apr 25, 2025.
Settlement Mar 31, 2025
887,113 shares short
+156,539 shares (+21.4%) vs Mar 14, 2025
Published Apr 9, 2025.
Settlement Mar 14, 2025
730,574 shares short
-18,102 shares (-2.4%) vs Feb 28, 2025
Published Mar 25, 2025.
Settlement Feb 28, 2025
748,676 shares short
-383,694 shares (-33.9%) vs Feb 14, 2025
Published Mar 11, 2025.
Settlement Feb 14, 2025
1,132,370 shares short
+33,963 shares (+3.1%) vs Jan 31, 2025
Published Feb 26, 2025.
Settlement Jan 31, 2025
1,098,407 shares short
-67,667 shares (-5.8%) vs Jan 15, 2025
Published Feb 11, 2025.
Settlement Jan 15, 2025
1,166,074 shares short
-11,073 shares (-0.9%) vs Dec 31, 2024
Published Jan 27, 2025.
Settlement Dec 31, 2024
1,177,147 shares short
+71,419 shares (+6.5%) vs Dec 13, 2024
Published Jan 10, 2025.
Settlement Dec 13, 2024
1,105,728 shares short
-7,983 shares (-0.7%) vs Nov 29, 2024
Published Dec 24, 2024.
Settlement Nov 29, 2024
1,113,711 shares short
+2,394 shares (+0.2%) vs Nov 15, 2024
Published Dec 10, 2024.
Settlement Nov 15, 2024
1,111,317 shares short
+32,097 shares (+3%) vs Oct 31, 2024
Published Nov 26, 2024.
Settlement Oct 31, 2024
1,079,220 shares short
-33,089 shares (-3%) vs Oct 15, 2024
Published Nov 11, 2024.
Settlement Oct 15, 2024
1,112,309 shares short
-94,956 shares (-7.9%) vs Sep 30, 2024
Published Oct 24, 2024.
Settlement Sep 30, 2024
1,207,265 shares short
-75,686 shares (-5.9%) vs Sep 13, 2024
Published Oct 9, 2024.
Settlement Sep 13, 2024
1,282,951 shares short
+255,975 shares (+24.9%) vs Aug 30, 2024
Published Sep 24, 2024.
Settlement Aug 30, 2024
1,026,976 shares short
+13,970 shares (+1.4%) vs Aug 15, 2024
Published Sep 11, 2024.
Settlement Aug 15, 2024
1,013,006 shares short
-20,105 shares (-1.9%) vs Jul 31, 2024
Published Aug 26, 2024.
Settlement Jul 31, 2024
1,033,111 shares short
-34,569 shares (-3.2%) vs Jul 15, 2024
Published Aug 9, 2024.
Settlement Jul 15, 2024
1,067,680 shares short
-78,789 shares (-6.9%) vs Jun 28, 2024
Published Jul 24, 2024.
Settlement Jun 28, 2024
1,146,469 shares short
+106,175 shares (+10.2%) vs Jun 14, 2024
Published Jul 10, 2024.
Settlement Jun 14, 2024
1,040,294 shares short
+7,096 shares (+0.7%) vs May 31, 2024
Published Jun 26, 2024.
Settlement May 31, 2024
1,033,198 shares short
-20,484 shares (-1.9%) vs May 15, 2024
Published Jun 11, 2024.
Settlement May 15, 2024
1,053,682 shares short
-30,767 shares (-2.8%) vs Apr 30, 2024
Published May 24, 2024.
Settlement Apr 30, 2024
1,084,449 shares short
+58,927 shares (+5.7%) vs Apr 15, 2024
Published May 9, 2024.
Settlement Apr 15, 2024
1,025,522 shares short
+492,561 shares (+92.4%) vs Mar 28, 2024
Published Apr 24, 2024.
Settlement Mar 28, 2024
532,961 shares short
+48,923 shares (+10.1%) vs Mar 15, 2024
Published Apr 9, 2024.
Settlement Mar 15, 2024
484,038 shares short
+89,422 shares (+22.7%) vs Feb 29, 2024
Published Mar 26, 2024.
Settlement Feb 29, 2024
394,616 shares short
+21,963 shares (+5.9%) vs Feb 15, 2024
Published Mar 11, 2024.
Settlement Feb 15, 2024
372,653 shares short
+44,633 shares (+13.6%) vs Jan 31, 2024
Published Feb 27, 2024.
Settlement Jan 31, 2024
328,020 shares short
+54 shares (0%) vs Jan 12, 2024
Published Feb 9, 2024.
Settlement Jan 12, 2024
327,966 shares short
+11,319 shares (+3.6%) vs Dec 29, 2023
Published Jan 24, 2024.
Settlement Dec 29, 2023
316,647 shares short
+23,121 shares (+7.9%) vs Dec 15, 2023
Published Jan 10, 2024.
Settlement Dec 15, 2023
293,526 shares short
+10,166 shares (+3.6%) vs Nov 30, 2023
Published Dec 26, 2023.
Settlement Nov 30, 2023
283,360 shares short
-6,855 shares (-2.4%) vs Nov 15, 2023
Published Dec 11, 2023.
Settlement Nov 15, 2023
290,215 shares short
-17,414 shares (-5.7%) vs Oct 31, 2023
Published Nov 24, 2023.
Settlement Oct 31, 2023
307,629 shares short
+2,700 shares (+0.9%) vs Oct 13, 2023
Published Nov 9, 2023.
Settlement Oct 13, 2023
304,929 shares short
-12,840 shares (-4%) vs Sep 29, 2023
Published Oct 24, 2023.
Settlement Sep 29, 2023
317,769 shares short
-4,865 shares (-1.5%) vs Sep 15, 2023
Published Oct 10, 2023.
Settlement Sep 15, 2023
322,634 shares short
-98 shares (0%) vs Aug 31, 2023
Published Sep 26, 2023.
Settlement Aug 31, 2023
322,732 shares short
-9,364 shares (-2.8%) vs Aug 15, 2023
Published Sep 11, 2023.
Settlement Aug 15, 2023
332,096 shares short
-3,890 shares (-1.2%) vs Jul 31, 2023
Published Aug 24, 2023.
Settlement Jul 31, 2023
335,986 shares short
-10,272 shares (-3%) vs Jul 14, 2023
Published Aug 9, 2023.
Settlement Jul 14, 2023
346,258 shares short
-16,287 shares (-4.5%) vs Jun 30, 2023
Published Jul 25, 2023.
Settlement Jun 30, 2023
362,545 shares short
+2,574 shares (+0.7%) vs Jun 15, 2023
Published Jul 11, 2023.
Settlement Jun 15, 2023
359,971 shares short
-20,918 shares (-5.5%) vs May 31, 2023
Published Jun 26, 2023.
Settlement May 31, 2023
380,889 shares short
-25,707 shares (-6.3%) vs May 15, 2023
Published Jun 9, 2023.
Settlement May 15, 2023
406,596 shares short
-5,479 shares (-1.3%) vs Apr 28, 2023
Published May 24, 2023.
Settlement Apr 28, 2023
412,075 shares short
+1,373 shares (+0.3%) vs Apr 14, 2023
Published May 9, 2023.
Settlement Apr 14, 2023
410,702 shares short
-5,784 shares (-1.4%) vs Mar 31, 2023
Published Apr 25, 2023.
Settlement Mar 31, 2023
416,486 shares short
+221,577 shares (+113.7%) vs Mar 15, 2023
Published Apr 11, 2023.
Settlement Mar 15, 2023
194,909 shares short
+94,528 shares (+94.2%) vs Feb 28, 2023
Published Mar 24, 2023.
Settlement Feb 28, 2023
100,381 shares short
+32,850 shares (+48.6%) vs Feb 15, 2023
Published Mar 9, 2023.
Settlement Feb 15, 2023
67,531 shares short
+1,986 shares (+3%) vs Jan 31, 2023
Published Feb 24, 2023.
Settlement Jan 31, 2023
65,545 shares short
-2,829 shares (-4.1%) vs Jan 13, 2023
Published Feb 9, 2023.
Settlement Jan 13, 2023
68,374 shares short
+1,721 shares (+2.6%) vs Dec 30, 2022
Published Jan 24, 2023.
Settlement Dec 30, 2022
66,653 shares short
-1,205 shares (-1.8%) vs Dec 15, 2022
Published Jan 10, 2023.
Settlement Dec 15, 2022
67,858 shares short
+20,751 shares (+44.1%) vs Nov 30, 2022
Published Dec 26, 2022.
Settlement Nov 30, 2022
47,107 shares short
Published Dec 9, 2022.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records. Adjusted prices exclude a reused ticker’s earlier issuer. FINRA data and reporting dates · How to read short interest
Portfolio context
Link an account to see your stake, watchlist and past holdings.
We’ll show you if ACRV is in your portfolio and how much it contributes.
Sign inMarket context
Smart money context
Holder IQ: MEDIUM
11 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Sep 22, 2026
Smart-money 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: bearish
Last trade: sell 18 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 0
Largest 13-F holders · Q2 2026
45 filers reported a long position in ACRV for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
93.9%
of the 21.4M shares 13-F filers reported
Moves vs Q1 2026
8 added1 trimmed
1 unchanged
Net shares held
+33.8%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Ra Capital Management, L.P. | $21.8M · 12.2M shares | 12.2M | +46.6% |
| 2 | Sands Capital Alternatives, LLC | $4.1M · 2.3M shares | 2.3M | +7.9% |
| 3 | Acadian Asset Management LLC | $2.1M · 1.2M shares | 1.2M | +37.7% |
| 4 | Vanguard Capital Management LLC | $1.7M · 952K shares | 952K | +31.9% |
| 5 | Wellington Management Group LLP | $1.6M · 888.1K shares | 888.1K | Unchanged |
| 6 | Renaissance Technologies LLC | $1.4M · 758.9K shares | 758.9K | +0.1% |
| 7 | Two Sigma Investments, LP | $1.1M · 641.5K shares | 641.5K | +64.7% |
| 8 | Marshall Wace, LLP | $946.7K · 531.9K shares | 531.9K | -5.1% |
| 9 | Bridgeway Capital Management, LLC | $674.4K · 378.9K shares | 378.9K | +138.5% |
| 10 | Geode Capital Management, LLC | $472.3K · 265.2K shares | 265.2K | +12.2% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of ACRV file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 13, 2026 | Sands Capital Life Sciences Pulse Fund II LP13G · passive · amended | 5.3% |
| May 15, 2026 | Citadel Advisors LLC13G · passive · amended | 0%under 5% |
| Apr 23, 2026 | Ra Capital Management, L.P.13D · activist · amended | 28.8% |
Moves the factor model did not explain
How much of ACRV’s move accompanied the market and its measured style leanings, and how much was left? The residual is unexplained by this fitted model. It does not establish a cause, skill or future alpha.
- Market
- -1.02%
- Style leanings
- -5.98%
- Unexplained residual
- -10.05%
- Stock move
- -17.05%
Window contributions are percentage points of starting stock value. The market bar is the fitted common intercept, not an index return. Market + styles + residual = stock move; opposite signs can offset. Source: daily_returns, dated security_factor_exposures × barra_factor_returns, and stored security_specific_returns; 2026-10-15–2026-11-12, model v1.2.0. Returns are dimensionless on the USD listing; no currency conversion.
Link an account with dated transactions to see what share of your own holding’s move since its purchase-date close was unexplained, with long and short positions distinguished. Your private holdings never enter this public chart.
Dated model observations (20)
Daily percentage returns, not window contributions. Source: the same dated warehouse rows and model v1.2.0; observed 2026-11-13T15:43:45.613Z. Absent sessions are never interpolated; missing or failed inputs stay unavailable.
| Date | Stock | Market | Styles | Residual |
|---|---|---|---|---|
| -6.82% | -1.05% | -5.98% | +0.21% | |
| +3.05% | +0.36% | +1.50% | +1.19% | |
| +6.21% | +0.43% | -0.48% | +6.27% | |
| +1.67% | +0.49% | +0.82% | +0.37% | |
| -3.56% | -1.09% | -8.38% | +5.91% | |
| -1.70% | -0.46% | +1.32% | -2.57% | |
| -0.58% | +0.50% | -0.16% | -0.93% | |
| +1.16% | +0.68% | +4.72% | -4.24% | |
| +2.87% | +0.37% | +2.26% | +0.25% | |
| -1.68% | -0.46% | +0.79% | -2.01% | |
| -5.68% | -1.77% | -7.03% | +3.12% | |
| -3.01% | -0.24% | -1.74% | -1.04% | |
| +3.73% | +0.35% | +4.09% | -0.71% | |
| +4.19% | +1.75% | -1.68% | +4.12% | |
| -9.77% | -3.95% | -8.50% | +2.68% | |
| +2.55% | +0.71% | +5.67% | -3.83% | |
| -1.86% | +2.42% | +9.29% | -13.57% | |
| -0.63% | -0.29% | +1.37% | -1.71% | |
| 0.00% | +1.19% | +1.98% | -3.17% | |
| -7.01% | -0.45% | -3.95% | -2.60% |
How this split is calculated
Each day uses that day’s fitted market intercept and style exposures multiplied by that day’s published factor returns. Their sum plus the independently stored residual must reconcile to the stock return. Window effects are weighted by stock wealth at each day’s start and added; the stock return compounds. Every expected US market session must be present and pass source, identity, model and numerical checks. This retrospective fit is an explanation of measured returns, not evidence of causation or an investable forecast. The window ends at the latest published model session, which can lag the market; today’s unfinished session is excluded.
What insiders reported owning
Reading dated filing evidence…
Get the Full Analysis for ACRV
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.